Amino acid compositions and their use for the treatment of traumatic brain injury
This disclosure provides pharmaceutical compositions comprising defined amino acid components, and methods for treating traumatic brain injury comprising administering an effective amount of the compositions to a subject in need thereof.
1. A composition comprising free amino acids and one or more pharmaceutically acceptable excipients, wherein the amino acids consist of leucine, isoleucine and valine, plus one or more of:
a. both of arginine and lysine;
b. all of glutamine, N-acetylcysteine and glycine;
c. methionine; and
d. proline,
as its defined amino acid components.
2. The composition of claim 1 , wherein the amino acids consist of leucine, isoleucine, valine, arginine, lysine, glutamine, N-acetylcysteine, glycine, methionine, and proline.
3. The composition of claim 1 , wherein the amino acids consist of leucine, isoleucine, valine, arginine, and lysine.
4. The composition of claim 1 , wherein the amino acids consist of leucine, isoleucine, valine, glutamine, N-acetylcysteine, and glycine.
5. The composition of claim 1 , wherein the amino acids consist of leucine, isoleucine, valine, arginine, lysine, glutamine, N-acetylcysteine, and glycine.
6. The composition of claim 1 , wherein the amino acids consist of leucine, isoleucine, valine, arginine, lysine, glutamine, N-acetylcysteine, glycine, and methionine or proline.
7. The composition of claim 1 , wherein the total weight of amino acids present is between 5 g and 75 g.
8. The composition of claim 1 , wherein the composition is a pharmaceutical composition comprising one or more pharmaceutically acceptable excipients.